MCID: HMS001
MIFTS: 41

Hemosiderosis malady

Categories: Rare diseases, Metabolic diseases

Aliases & Classifications for Hemosiderosis

About this section

Aliases & Descriptions for Hemosiderosis:

Name: Hemosiderosis 10 45 47 12 36 65
 
Haemosiderosis 10

Classifications:



External Ids:

Disease Ontology10 DOID:12119
MeSH36 D006486
SNOMED-CT59 190849009, 39011001
NCIt42 C82892
UMLS65 C0019114

Summaries for Hemosiderosis

About this section
Disease Ontology:10 An iron metabolism disease that has material basis in an accumulation of hemosiderin, an iron-storage complex, resulting in iron overload.

MalaCards based summary: Hemosiderosis, also known as haemosiderosis, is related to pyruvate kinase deficiency and malaria. An important gene associated with Hemosiderosis is CP (Ceruloplasmin (Ferroxidase)), and among its related pathways are African trypanosomiasis and O2/CO2 exchange in erythrocytes. The drug cyclophosphamide has been mentioned in the context of this disorder. Affiliated tissues include liver, breast and heart, and related mouse phenotypes are liver/biliary system and hematopoietic system.

Wikipedia:68 Hemosiderosis (AmE) or haemosiderosis (BrE) is a form of iron overload disorder resulting in the... more...

Related Diseases for Hemosiderosis

About this section

Diseases related to Hemosiderosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 382)
idRelated DiseaseScoreTop Affiliating Genes
1pyruvate kinase deficiency30.0EPO, HFE
2malaria28.8EPO, HBA1, HBB, TFRC
3pulmonary hemosiderosis12.6
4secondary pulmonary hemosiderosis12.3
5gracile syndrome11.5
6cerebellar ataxia11.5
7aceruloplasminemia11.5
8guillain-barre syndrome10.4CP, TF
9superficial siderosis10.4
10duane-radial ray syndrome10.4CP, TF
11early-onset, autosomal dominant alzheimer disease10.3CP, TF
12breast cancer10.3
13bladder neck cancer10.3CP, TF
14polycythemia due to hypoxia10.3EPO, HBB
15fatal infantile encephalocardiomyopathy10.3CP, FTL
16xanthogranulomatous pyelonephritis10.3CP, TF
17thbd-related atypical hemolytic-uremic syndrome10.3EPO, HBB
18nonsyndromic 46,xx testicular disorders of sex development10.3CP, FTL
19methylmalonic aciduria and homocystinuria type cble10.3EPO, TF
20baraitser brett piesowicz syndrome10.3HFE, TF
21acute kidney failure10.3EPO, HBB
22neuronitis10.2
23nutritional deficiency disease10.2CP, HFE
24snyder-robinson syndrome10.2EPO, HBB
25hepatitis10.2
26lymphoma10.2
27retinitis10.2
28endotheliitis10.2
29epidermolysis bullosa dystrophica10.2EPO, TF
30dermoid cyst of ovary10.2CP, EPO, TF
31cognitive impairment with or without cerebellar ataxia10.1CP, HBB, TF
32discitis10.1EPO, TFRC
33leukemia10.1
34cervicitis10.1
35thyroiditis10.1
36gastric small cell carcinoma10.1HFE, TF
37spinocerebellar ataxia 810.1CP, HFE
38malignant adult ependymoma10.1EPO, HBB, TF
39thymus mucoepidermoid carcinoma10.1EPO, TF
40heart disease10.1EPO, TF
41undetermined early-onset epileptic encephalopathy10.1HFE, TFRC
42rheumatoid arthritis10.1
43hiv-110.1
44leigh syndrome10.1
45obesity10.1
46arthritis10.1
47glomerulonephritis10.1
48dementia10.1
49melanoma10.1
50adenocarcinoma10.1

Graphical network of the top 20 diseases related to Hemosiderosis:



Diseases related to hemosiderosis

Symptoms for Hemosiderosis

About this section

Drugs & Therapeutics for Hemosiderosis

About this section

Drugs for Hemosiderosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 11)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
DeferiproneapprovedPhase 4, Phase 3, Phase 25330652-11-02972
Synonyms:
1,2-Dimethyl-3-hydroxypyrid-4-one
3-Hydroxy-1,2-dimethyl-4(1H)-pyridone
APO-066
CP-20
DN-180-01-AF
Deferipron
 
Deferiprona
Deferiproni
Deferipronum
Deferypron
Dimethylhydroxypyridone
Défériprone
Ferriprox
PL-1
2
IronapprovedPhase 4, Phase 3, Phase 210217439-89-623925
Synonyms:
02583_FLUKA
12310_ALDRICH
12310_RIEDEL
129048-51-7
14067-02-8
161135-39-3
190454-13-8
195161-83-2
199281-22-6
209309_ALDRICH
209309_SIAL
255637_ALDRICH
266213_ALDRICH
266256_ALDRICH
267945_ALDRICH
267953_ALDRICH
26Fe
338141_ALDRICH
356808_ALDRICH
356824_ALDRICH
356832_ALDRICH
39344-71-3
3ZhP
413054_ALDRICH
443783-52-6
44890_ALDRICH
44890_FLUKA
675141-17-0
70884-35-4
73135-38-3
7439-89-6
8011-79-8
8053-60-9
AC1L2N38
ATW 230
ATW 432
Ancor B
Ancor en 80/150
Armco iron
Atomel 28
Atomel 300M200
Atomel 500M
Atomel 95
Atomiron 44MR
Atomiron 5M
Atomiron AFP 25
Atomiron AFP 5
C00023
C3518_SIAL
C3518_SIGMA
CCRIS 1580
CHEBI:18248
CID23925
Carbonyl iron
Copy Powder CS 105-175
D007501
DB01592
DSP 1000
DSP 128B
DSP 135
DSP 135C
DSP 138
Dexiron
Diseases (animal), iron overload
Diseases, iron overload
EF 1000
EF 250
EFV 200/300
EFV 250
EFV 250/400
EINECS 231-096-4
Ed-In-Sol
 
Eisen
F 60 (metal)
FE
FT 3 (element)
Fe
Fe-40
Fe1+
Feraheme
Feronate
Ferretts
Ferrlecit
Ferro-Caps
Ferro-Time
Ferrousal
Ferrovac E
Ferrum
GS 6
HF 2 (element)
HL (iron)
HQ (metal)
HS (iron)
HS 4849
HSDB 604
Hemocyte
Hierro
Hoeganaes ATW 230
Hoeganaes EH
IRMM524A_FLUKA
IRMM524B_FLUKA
IRON
Infufer
Iron
Iron (Fe)
Iron (Fe1+)
Iron ion (Fe+)
Iron ion(1+)
Iron monocation
Iron standard for AAS
Iron(1+)
Iron(1+) ion
Iron(III) nitrate solution
Iron, elemental
Iron, ion (Fe1+)
Iron, ion (Fe1+) (8CI,9CI)
LOHA
LS-3196
MolPort-003-925-001
NC 100
PZh-1M3
PZh-2
PZh1M1
PZh2M
PZh2M1
PZh2M2
PZh3
PZh3M
PZh4M
PZhO
Remko
SUY-B 2
Siderol
UNII-E1UOL152H7
Venofer
Vitedyn-Slo
Yieronia
fer
ferrous ascorbate
ferrous fumarate
ferrous gluconate
ferrous glycine sulfate
ferrous iron
ferrous succinate
ferrous sulfate
hierro
3
Deferoxamineapproved, investigationalPhase 4, Phase 3, Phase 24470-51-92973
Synonyms:
DF B
DFO
DFOA
DFOM
Deferoxamide B
Deferoxamin
Deferoxamina
Deferoxamine
Deferoxamine B
Deferoxamine Hydrochloride
 
Deferoxamine Mesylate
Deferoxamine mesylate
Deferoxaminum
Deferrioxamine
Deferrioxamine B
Deferrioxamine b
Desferal
Desferrioxamine
Desferrioxamine B
Déferoxamine
N-Benzoylferrioxamine B
4
Deferasiroxapproved, investigationalPhase 4, Phase 3, Phase 286201530-41-85493381
Synonyms:
Deferasiroxum
Deferasiroxum [inn-latin]
 
Exjade
ICL 670
ICL 670a
deferasirox
5Chelating AgentsPhase 4, Phase 3, Phase 2667
6Iron Chelating AgentsPhase 4, Phase 3, Phase 2178
7Liver ExtractsPhase 2, Phase 33572
8
Epoetin alfaapprovedPhase 2626113427-24-0
Synonyms:
Epogen
 
Erythropoietin precursor
Procrit
9HematinicsPhase 21121
10
Benzocaineapproved16841994-09-7, 94-09-72337
Synonyms:
(p-(Ethoxycarbonyl)phenylamine
06952_FLUKA
112909_ALDRICH
112909_SIAL
1333-08-0
20/20 Topical Anesthetic
23239-88-5
23239-88-5 (hydrochloride)
4 Aminobenzoic Acid Ethyl Ester
4-(Ethoxycarbonyl)aniline
4-(Ethoxycarbonyl)phenylamine
4-14-00-01129 (Beilstein Handbook Reference)
4-Aminobenzoate
4-Aminobenzoic acid
4-Aminobenzoic acid ethyl ester
4-Aminobenzoic acid, ethyl ester
4-Carbethoxyaniline
4-amino-benzoic acid ethyl ester
4-aminobenzoic acid ethyl ester
71123-91-6
94-09-7
94-09-7 (Parent)
A0271
AB00051923
AC1L1DGC
AC1Q341A
AC1Q64JE
AE-562/40377256
AI3-02081
AKOS000119763
AR-1H9065
Acetate, Benzocaine
Aethoform
Aethylium paraminobenzoicum
Alcohol Prep Pads
Allegenal-m
Alpha-caine Topical Anesthetic
Amben ethyl ester
Americaine
Anaesthan-syngala
Anaesthesin
Anaesthesinum
Anaesthin
Anbesol Jr
Anbesol Maximum Strength
Anbesol Regular Strength
Anestenka
Anestezin
Anestezin [Russian]
Anesthesin
Anesthesine
Anesthetic
Anesthone
Atopalm Oral Pain Relief
BB_SC-0019
BPBio1_001017
BRD-K75466013-001-05-2
BRN 0638434
BSPBio_000923
BSPBio_001908
Baby Anbesol
Baby Anestenka
Baby Sensigel
Baby Sensigel Night Time Formula
Baby Teething Oral Pain Reliever
Bactimicina For Sore Throat
Bencocaine Topical Anesthetic
Bensokain
Benz O Sthetic
Benzoak
Benzocaina
Benzocaina [INN-Spanish]
Benzocaine
Benzocaine (USP/INN)
Benzocaine Acetate
Benzocaine Formate
Benzocaine Hydrobromide
Benzocaine Hydrochloride
Benzocaine Methanesulfonate
Benzocaine [INN:BAN]
Benzocainum
Benzocainum [INN-Latin]
Benzodent
Benzoic acid, 4-amino-, ethyl ester
Benzoic acid, 4-amino-, ethyl ester, hydrochloride
Benzoic acid, amino-, ethyl ester
Benzoic acid, p-amino-, ethyl ester
Boil Ease
Boy Butter Desensitizing Lubricant
Boy Butter Extreme Desensitizing Lubricant
Boy Butter Extreme H2O Desensitizing Lubricant
Brace Relief
Budpak Baby Teething Oral Pain Reliever
Budpak Oral Maximum Strength
C07527
CAS-94-09-7
CHEBI:116735
CHEMBL278172
CID2337
Carmex Cold Sore Treatment External Analgesic
Caswell No. 430A
Cepacol Fizzlers
Cepacol Sensations Hydra
Cepacol Sensations Sore Throat Hydra citrus splash
Cepacol Sensations Warming
Certus Sting Relief Prep Pad
Chloraseptic
Chloraseptic Warming Sore Throat
Colgate Orabase
Comfortcaine Topical Anesthetic
Cvs Fast Acting Baby Teething
Cvs Maximum Strength
Cvs Maximum Strength Boil Relief
Cvs Oral Anesthetic
Cvs Pharmacy Instant Toothache
Cvs Pharmacy Maximum Strength
Cvs Pharmacy Mouth Sore Gel
Cvs Pharmacy Nighttime Oral Pain Relief
D001566
D00552
DB01086
Dental Relief
Dentek Instant Pain Relief Maximum Strength
Dermoplast
Diet Ayds
DivK1c_000932
Dollar General Toothache Relief
Dukal Sting Relief Pad
E1501_SIGMA
EINECS 202-303-5
EPA Pesticide Chemical Code 097001
ETHYL-P-AMINOBENZOATE
Ethoform
Ethoforme
Ethyl 4-aminobenzoate
Ethyl 4-aminobenzoate hydrochloride
Ethyl 4-aminobenzoic acid
Ethyl Aminobenzoate
Ethyl PABA
Ethyl aminobenzoate
Ethyl aminobenzoate (JP15)
Ethyl aminobenzoate (VAN)
Ethyl aminobenzoic acid
Ethyl p-Aminobenzoate
Ethyl p-Aminophenylcarboxylate
Ethyl p-aminobenzenecarboxylate
Ethyl p-aminobenzoate
Ethyl p-aminobenzoic acid
Ethyl p-aminophenylcarboxylate
Ethylester kyseliny p-aminobenzoove
Ethylester kyseliny p-aminobenzoove [Czech]
Ethylis aminobenzoas
Finafta Baby
Finafta MultiOral
Formate, Benzocaine
Gelato Topical Anesthetic
Good Neighbor Pain Relief
Goodsense Oral Pain Relief
Gps Topical Anesthetic
Gumnumb Topical Anesthetic
HMS1570O05
HMS1920G09
HMS2091M11
HMS502O14
HSDB 7225
Heb Severe Toothache
Herbasoul Male Genital Desensitizer Cream
 
Hurricaine
Hurricaine Topical Anesthetic
Hurricaine Topical Anesthetic Gel
Hurricaine Topical Anesthetic Liquid
Hydrobromide, Benzocaine
Hydrochloride, Benzocaine
I05-0204
IDI1_000932
Identhesin
Insect Bite Relief
Instant Toothache Pain Relief
Intense Cvs Intense Toothache
Iodent Maximum Strength Oral Analgesic
Ismile Topical Anesthetic
Jianze Sting Relief Pads
KBio1_000932
KBio2_000474
KBio2_003042
KBio2_005610
KBio3_001408
KBioGR_000658
KBioSS_000474
Kank-a Mouth Pain
Keloform
Kmart Smart Sense
Kroger Toothache Pain Relief
LS-35847
Leader Oral Analgesic
Little Colds Sore Throat Relief Melt Aways
MLS001331704
MLS002153970
Makesense Junior Pain Relief
Makesense Pain Relief
Male Desensitizer Pleasure Balm
Mandelay Male Genital Desensitizer
Mark 3
Methanesulfonate, Benzocaine
MolPort-000-871-526
Mouth Sore Medication
Mouth Sore Relief Applicator
Mouth Sore Relief Professional Strength
My Fair Baby Instant Pain Relief
NCGC00016352-01
NCGC00094598-01
NCGC00094598-02
NINDS_000932
NSC 122792
NSC 41531
NSC41531
NSC4688
Nene Dente
Norcain
Norcaine
Norcainum
Opahl
Opahl Dye Free
Oprea1_750694
Oprea1_827402
Ora-jel
Orabase-B
Orajel For All Mouth Sores Maximum Strength
Orajel For Cold Sores
Orajel For Toothache Maximum Strength
Orajel Instant Pain Relief Maximum Strength
Orajel Instant Pain Relief Regular Strength
Orajel Instant Relief For Teething Pain
Orajel Instant Relief For Teething Pain Cooling Cucumber
Orajel Instant Relief For Teething Pain Daytime Nighttime Twin Pack
Orajel Instant Relief For Teething Pain Longer Lasting
Orajel Maximum Strength
Orajel Nighttime Instant Relief For Teething Pain Longer Lasting Extra Strength
Orajel Severe Toothache Maximum Strength Fast-Acting Formula
Oral Analgesic Maximum Strength
Oral B Instant Pain Relief
Oral Gel Maximum Strength
Oral Pain Relief Anesthetic Anesthetic
Oral Pain Reliever
Oralabs Cold Sore Treatment
Orthesin
Otocain
Outgro
Pac-dent Top Gel
Pain Relief
Pain Relief Alcohol Swabs
Parathesin
Parathesin (TN)
Parathesine
Physicians Care Sting Relief Pad
Pleasure Balm Kama Sutra
Preboost
Prestwick0_000712
Prestwick1_000712
Prestwick2_000712
Prestwick3_000712
Prestwick_991
Purelife Topical Anesthetic
Quality Choice Maximum Strength Oral Pain Relieving
Red Cross Oral Pain Relief
Rexall Maximum Strength
Rite Aid Baby Care
Rite Aid Liquid Anesthetic Oral Pain Relief
Rite Aid Maximum Strength
Rite Aid Oral Pain Reliever
Rite Aid Professional Strength
SMR000059025
SPBio_000134
SPBio_002844
SPECTRUM1500139
STK043620
Sally Hansen Ouch-relief Numbing Wipes
Sally Hansen Ouch-relief Wax Kit
Sally Hansen Ouch-relief Wax Strip Kit
Sensigel
Severe Oral Pain Reliever
Sheffield Baby Teething Gel
Sheffield Pain Relief
Shunga Male Genital Desensitizer
Slim Mint Gum
Solarcaine
Solu H
Spectrum2_000117
Spectrum3_000314
Spectrum4_000249
Spectrum5_000860
Spectrum_000074
Sting Relief Medicated Pad
Sting Relief Pads
Tanac
Terrasil Boil Pain Relief
Tiger Supply Inc Topical Anesthetic
Top Quality Mfg. Topical Anesthetic
Topcaine
Topcare Maximum Strength
Topical Anesthetic Banana
Topical Anesthetic Bubble Gum
Topical Anesthetic Cherry
Topical Anesthetic Mint
Topical Anesthetic Pina Colada
Topical Anesthetic Raspberry
Topical Anesthetic Strawberry
UNII-U3RSY48JW5
Ultracare Anesthetic Bubble Gum
Ultracare Anesthetic Butter Rum
Ultracare Anesthetic Creme de Menthe
Ultracare Anesthetic Pina Colada
Ultracare Anesthetic Walterberry
WLN: ZR DVO2
Walgreens Baby Teething
Walgreens Intense Toothache
Walgreens Maximum Strength
Walgreens Pain Relieving For Boils
Walgreens Severe Oral Pain Reliever
Walgreens Severe Toothache Relief
Winco Foods Maximum Strength Oral Analgesic
ZINC12358719
Zilactin-b
benzocaine
ethylaminobenzoate-4
h-4-abz-oet
nchembio.182-comp4
p-(Ethoxycarbonyl)aniline
p-Aminobenzoate
p-Aminobenzoic acid
p-Aminobenzoic acid ethyl ester
p-Aminobenzoic acid, ethyl ester
p-Aminobenzoic ethyl ester
p-Carbethoxyaniline
p-Ethoxycarboxylic Aniline
p-Ethoxycarboxylic aniline
11tannic acidNutraceutical1684

Interventional clinical trials:

(show all 31)
idNameStatusNCT IDPhase
1Extension Study of the Efficacy and Safety of Deferasirox Treatment in Beta-thalassemia Patients With Transfusional Hemosiderosis (Study Amended to 2-year Duration)CompletedNCT00171301Phase 4
2Efficacy Study in Removing Excess Iron From the HeartCompletedNCT00105495Phase 4
3Palatability and Tolerability of Deferasirox Taken With Meals, With Different Liquids or Crushed and Added to FoodCompletedNCT00845871Phase 4
4ENTRUST, a 5 Year Surveillance of Children Aged 2 to <6 Years With Transfusional Iron Overload Treated With DeferasiroxCompletedNCT00466063Phase 4
5Efficacy and Safety of Oral Deferasirox (20 mg/kg/d) in Pts 3 to 6 Months After Allogeneic Hematopoietic Cell Transplantation Who Present With Iron OverloadCompletedNCT00654589Phase 4
6Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron OverloadCompletedNCT00481143Phase 4
7Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic AnemiaCompletedNCT01546415Phase 4
8Safety, Tolerability, and Efficacy of Deferasirox in MDSCompletedNCT00469560Phase 3
9A Study of Long-term Treatment With Deferasirox in Patients With Beta-thalassemia and Transfusional HemosiderosisCompletedNCT00171171Phase 3
10Safety & Efficacy of ICL670 vs. Deferoxamine in Beta-thalassemia Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00061750Phase 3
11Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron OverloadNot yet recruitingNCT01511848Phase 2, Phase 3
12Efficacy and Safety of Deferasirox in Patients With Chronic Anemia and Transfusional HemosiderosisCompletedNCT00631163Phase 2
13Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia PatientsCompletedNCT00303329Phase 2
14Evaluating Use of Deferasirox as Compared to Deferoxamine in Treating Cardiac Iron OverloadCompletedNCT00600938Phase 2
15Safety of ICL670 vs. Deferoxamine in Sickle Cell Disease Patients With Iron Overload Due to Blood TransfusionsCompletedNCT00067080Phase 2
16Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO).CompletedNCT01090323Phase 2
17Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic AnemiasCompletedNCT00061763Phase 2
18A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe ToxicityCompletedNCT01044186Phase 2
19Treatment of Anemia With Epoetin Beta in Low Risk Myelodysplastic Syndrome (MDS)CompletedNCT02428686Phase 2
20Treatment of Iron Overload Requiring Chelation TherapyWithdrawnNCT01927913Phase 2
21Single and Multiple Ascending Dose Study of BIIB037 in Japanese Participants With Alzheimer's DiseaseActive, not recruitingNCT02434718Phase 1
22Observation of Patients With Transfusional Hemosiderosis Treatment With DeferasiroxCompletedNCT01394029
23Pharmacogenetic Study in Patients Received Iron Chelating AgentCompletedNCT01623895
24Non-invasive Quantification of Liver Iron With MRICompletedNCT01516853
25Confounder-Corrected Quantitative MRI Biomarker of Hepatic Iron ContentRecruitingNCT02025543
26Added Value of Speckle Tracking in the Evaluation of Patients With Sickle Cell DiseaseRecruitingNCT02394431
27Detection of β Thalassemia Carriers by Red Cell Parameters Obtained From the H2 Automatic CounterRecruitingNCT00481221
28PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to AdulthoodRecruitingNCT00652964
29A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients.Enrolling by invitationNCT01935661
30Florbetaben as an Amyloid Plaque Marker in Elderly Patients With Focal or Disseminated Superficial HemosiderosisNot yet recruitingNCT02664571
31Red Blood Cell Transfusion Thresholds and QOL in MDSNot yet recruitingNCT02099669

Search NIH Clinical Center for Hemosiderosis

Inferred drug relations via UMLS65/NDF-RT43:


Cochrane evidence based reviews: hemosiderosis

Genetic Tests for Hemosiderosis

About this section

Anatomical Context for Hemosiderosis

About this section

MalaCards organs/tissues related to Hemosiderosis:

33
Liver, Breast, Heart, Brain, T cells, Endothelial, Bone

Animal Models for Hemosiderosis or affiliated genes

About this section

MGI Mouse Phenotypes related to Hemosiderosis:

38
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053707.9CP, EPO, FTH1, HFE, TFRC
2MP:00053977.5CP, EPO, FTH1, HFE, TF, TFRC

Publications for Hemosiderosis

About this section

Articles related to Hemosiderosis:

(show top 50)    (show all 475)
idTitleAuthorsYear
1
Identification of Novel 14-3-3 Residues That Are Critical for Isoform-specific Interaction with GluN2C to Regulate N-Methyl-D-aspartate (NMDA) Receptor Trafficking. (26229101)
2015
2
A case of Hodgkin lymphoma in a patient with a history of bone pain and an initial diagnosis of chronic osteomyelitis. (25908041)
2015
3
Analysis of 27 vascular-related proteins reveals that NT-proBNP is a potential biomarker for Alzheimer's disease and mild cognitive impairment: A pilot-study. (24333505)
2014
4
Identifying chemicals with potential therapy of HIV based on protein-protein and protein-chemical interaction network. (23762317)
2013
5
Elevated serum levels of macrophage migration inhibitory factor are associated with progressive chronic cardiomyopathy in patients with Chagas disease. (23451183)
2013
6
Value of CD10 Expression in Differentiating Cutaneous Basal from Squamous Cell Carcinomas and Basal Cell Carcinoma from Trichoepithelioma. (23825889)
2013
7
Lack of MYD88 L265P in non-immunoglobulin M lymphoplasmacytic lymphoma. (23915224)
2013
8
H-ras oncogene expression and angiogenesis in experimental liver cirrhosis. (24235967)
2013
9
Exploring inequalities in access to care and the provision of choice to women seeking breast reconstruction surgery: a qualitative study. (23928662)
2013
10
The tumor suppressor protein menin inhibits NF-I_B-mediated transactivation through recruitment of Sirt1 in hepatocellular carcinoma. (23224434)
2013
11
BK virus nephropathy in simultaneous pancreas kidney transplant: a potentially preventable cause of kidney allograft loss. (22448973)
2012
12
Overexpression of c-Met in cervical intraepithelial neoplasia. (23327059)
2012
13
Population-based study of hypoglycemia in patients with type 1 diabetes mellitus requiring emergency medical services. (22784848)
2012
14
Diaphragm pacing and noninvasive respiratory management of amyotrophic lateral sclerosis/motor neuron disease. (23042087)
2012
15
Monthly variation in acute appendicitis incidence: a 10-year nationwide population-based study. (22795352)
2012
16
Neuroprotective effect of acute ethanol administration in a rat with transient cerebral ischemia. (22052512)
2012
17
Efficient secretion of small proteins in mammalian cells relies on Sec62-dependent posttranslational translocation. (22648169)
2012
18
I+-Synuclein expression in rat substantia nigra suppresses phospholipase D2 toxicity and nigral neurodegeneration. (20664530)
2010
19
A randomized, double-blinded, crossover pilot study assessing the effect of nabilone on spasticity in persons with spinal cord injury. (20434606)
2010
20
Heat stimulation reduces early adipogenesis in 3T3-L1 preadipocytes. (19277908)
2009
21
Factors determining changes in concentrations of pro-inflammatory markers in blood serum in the initial period after kidney transplantation from dead donor. (20009149)
2009
22
Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma. (19874554)
2009
23
Cryo-electron microscopy of coagulation Factor VIII bound to lipid nanotubes. (18039465)
2008
24
FGFR2 gene mutation in a family with Crouzon syndrome and a sporadic Crouzon syndrome patient]. (18393251)
2008
25
Evidence that resistance to nilotinib may be due to BCR-ABL, Pgp, or Src kinase overexpression. (19047160)
2008
26
New onset or exacerbation of psoriatic skin lesions in patients with definite rheumatoid arthritis receiving tumour necrosis factor alpha antagonists. (16150791)
2006
27
Thoracoscopic management of spontaneous pneumothorax during pregnancy. (16165137)
2005
28
Repeatability of 2 methods for assessment of insulin sensitivity and glucose dynamics in horses. (16355685)
2005
29
Pyloromyotomy in a patient with paramyotonia congenita. (14693588)
2004
30
Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation. (15164793)
2004
31
Degradation of retinoid X receptor alpha by TPA through proteasome pathway in gastric cancer cells. (12970875)
2003
32
Myeloperoxidase-positive inflammatory cells participate in bile duct damage in primary biliary cirrhosis through nitric oxide-mediated reactions. (14512889)
2003
33
Upregulation of alpha-synuclein by lipopolysaccharide and interleukin-1 in human macrophages. (12406186)
2002
34
Axillary lymph node cellular immune response to HER-2/neu peptides in patients with carcinoma of the breast. (12060497)
2002
35
A rapid ELISA-based serum assay for myelin basic protein in multiple sclerosis. (11983216)
2002
36
FTY720, a novel immunosuppressive agent, induces apoptosis in human glioma cells. (11181042)
2001
37
Treatment of metastatic renal cell carcinoma with activated autologous macrophages and granulocyte--macrophage colony-stimulating factor. (11186156)
2000
38
Polysymptomatic conversion disorder in childhood and adolescence in Japan. Early manifestation or incomplete form of somatization disorder? (10773777)
2000
39
The role of mitochondria in apoptosis. (12937660)
2000
40
Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours. (10383595)
1999
41
Vaccine effect of granulocyte-macrophage colony-stimulating factor or CD80 gene-transduced murine hematopoietic tumor cells and their cooperative enhancement of antitumor immunity. (9930341)
1998
42
Autonomic dysfunction in chronic intestinal pseudo-obstruction. (9869551)
1998
43
Osteoid osteoma or osteoblastoma of the cervical spine in relation to the vertebral artery. (7814596)
1994
44
Expression of messenger ribonucleic acids encoding for basic fibroblast growth factor (FGF) and alternatively spliced FGF receptor in human fetal ovary and uterus. (8077334)
1993
45
1,3-Butadiene oxidation by human myeloperoxidase. Role of chloride ion in catalysis of divergent pathways. (1328183)
1992
46
The impact of economic considerations on clinical decisionmaking: the case of thrombolytic therapy. (1921539)
1991
47
Trophoblastic differentiation of human teratocarcinoma cell line HT-H1. (2426151)
1986
48
Presynaptic dopamine receptor stimulation and the antihypertensive action of pergolide in experimental neurogenic hypertension. (7122527)
1982
49
Report of a case of true hermaphroditism with karyotype 45,X/46,XX/46,X,mar/47,XX,mar. (563432)
1977
50
A case of septic iridocyclitis. (18934802)
1948

Variations for Hemosiderosis

About this section

Expression for genes affiliated with Hemosiderosis

About this section
Search GEO for disease gene expression data for Hemosiderosis.

Pathways for genes affiliated with Hemosiderosis

About this section

Pathways related to Hemosiderosis according to GeneCards Suite gene sharing:

(show all 12)
idSuper pathwaysScoreTop Affiliating Genes
19.5HBA1, HBB
2
Show member pathways
9.5HBA1, HBB
39.5HBA1, HBB
49.2FTH1, FTL, TF
59.1EPO, TF, TFRC
69.0FTH1, TF, TFRC
7
Show member pathways
8.9FTH1, FTL, TFRC
88.8CP, EPO, TF, TFRC
9
Show member pathways
8.6FTH1, FTL, HBA1, HBB
10
Show member pathways
8.2CP, FTH1, FTL, TF, TFRC
11
Show member pathways
8.2CP, FTH1, FTL, TF, TFRC
12
Show member pathways
7.9FTH1, FTL, HBA1, HBB, TFRC

GO Terms for genes affiliated with Hemosiderosis

About this section

Cellular components related to Hemosiderosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1haptoglobin-hemoglobin complexGO:003183810.0HBA1, HBB
2cytoplasmic, membrane-bounded vesicleGO:00160239.5TF, TFRC
3cell surfaceGO:00099869.2TF, TFRC

Biological processes related to Hemosiderosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1protein heterooligomerizationGO:00512919.4HBA1, HBB
2iron ion homeostasisGO:00550729.2FTL, HFE, TF
3acute-phase responseGO:00069539.1EPO, HFE, TFRC
4receptor-mediated endocytosisGO:00068988.9HBA1, HBB, TFRC
5cellular iron ion homeostasisGO:00068798.8FTH1, FTL, TF, TFRC
6transmembrane transportGO:00550858.3CP, FTH1, FTL, TF, TFRC

Molecular functions related to Hemosiderosis according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1haptoglobin bindingGO:00317209.7HBA1, HBB
2ferric iron bindingGO:00081999.6FTH1, FTL
3peroxidase activityGO:00046019.5HBA1, HBB

Sources for Hemosiderosis

About this section
2CDC
14ExPASy
15FDA
16FMA
24GTR
25HGMD
26HMDB
27ICD10
28ICD10 via Orphanet
29ICD9CM
30IUPHAR
31KEGG
34MedGen
36MeSH
37MESH via Orphanet
38MGI
41NCI
42NCIt
43NDF-RT
46NINDS
47Novoseek
49OMIM
50OMIM via Orphanet
54PubMed
55QIAGEN
60SNOMED-CT via Orphanet
64Tumor Gene Family of Databases
65UMLS
66UMLS via Orphanet